Bibliographic information

GuidelineClinical management of COVID-19: living guideline, 15 September 2022.
Year of Publication2022
Issuing InstitutionWHO

Recommendation

Maintained

For symptomatic patients with COVID-19 and risk factors for progression to severe disease who are not hospitalized, the WHO suggests the use of pulse oximetry monitoring at home as part of a package of care, including patient and provider education and appropriate follow-up.

Recommended in favor

Conditional

Notes and Remarks

Practical Info The GDG made a conditional recommendation for the use of home pulse oximetry monitoring. This recommendation is predicated on the availability and accessibility of high-quality and reliable pulse oximeters for home use; the integration of home pulse oximetry into a health system, from a training and human resources perspective; and targeting the intervention to patients who would likely get the most benefit, namely those at high-risk and those who are symptomatic. Also, no recommendation was made on the frequency or duration of pulse oximetry monitoring. Note: training on appropriate IPC (cleaning and disinfection) should be included.

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

COVID-19 clinical management: living guidance, 25 January 2021.

Year2021
InstitutionWorld Health Organization
Guideline

Living guidance for clinical management of COVID-19: living guidance, 23 November 2021.

Year2021
InstitutionWorld Health Organization
Guideline

Clinical management of COVID-19: living guideline, 23 June 2022.

Year2022
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 13 January 2023.

Year2023
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, 18 August 2023

Year2023
InstitutionWHO
Guideline

Clinical management of COVID-19: living guideline, June 2025

Year2025
InstitutionWorld Health Organization